Vimta Labs Limited share price
NSE: VIMTALABS · ISIN INE579C01029
Key numbers
- Market cap
- ₹ 2,679 Cr
- Current price
- ₹ 599.30
- 52-week high / low
- ₹ 775 / 376
- Stock P/E
- 33.5
- Book value
- ₹ 102.3
- Dividend yield
- 0.33%
- ROCE
- 24.6%
- ROE
- 18.5%
- Debt to equity
- 0.01
- Sales growth (3 yrs)
- 8.9%
- Profit growth (3 yrs)
- 17.2%
- 1-year return
- -18.1%
About Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 98 | 102 | 99 | 109 | 109 |
| Operating profit | 34 | 34 | 34 | 39 | 37 |
| Net profit | 19 | 20 | 18 | 21 | 21 |
| EPS (₹) | 4.25 | 4.46 | 3.96 | 4.73 | 4.71 |
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.